The consequence of COVID-19 on the global supply of medical products: Why Indian generics matter for the world? [version 1; peer review: 3 approved, 1 approved with reservations]
While the world is facing the urgency of the COVID-19 pandemic, policymakers must plan for the direct response to the outbreak while minimising its collateral impact. Maintaining the supply chain of pharmaceutical products is not only paramount to cover the immediate medical response but will be fun...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2020-04-01
|
Series: | F1000Research |
Online Access: | https://f1000research.com/articles/9-225/v1 |